Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Celltech Group claims new series of squaric acid derivatives

Jan. 22, 2001

MMP inhibitors from Pfizer reportedly useful for inflammatory disorders and cancer

Jan. 22, 2001

Two new clinical trials commence with Genasense for leukemia

Jan. 22, 2001

FDA denies approval of Aronex's Atragen for APL

Jan. 22, 2001

Antitumor compounds active against solid tumors and leukemias in the ADIR pipeline

Jan. 19, 2001

Halofuginone affects critical steps in the angiogenic process

Jan. 19, 2001

Worldwide licensing arrangement announced for TZT-1027

Jan. 19, 2001

Aphton to commence study of GnRH pharmaccine in combination with Taxotere

Jan. 19, 2001

Study of RSR-13 in combination with chemotherapy commences

Jan. 19, 2001

Bioniche's MCC technology approved for prostate cancer clinical trials

Jan. 19, 2001

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 17, 2026.
Biohaven reports details on discovery of BHV-2100
BioWorld Science
Transient receptor potential melastatin 3 (TRPM3) is a calcium-permeable TRP channel that is highly expressed in somatosensory neurons, including nociceptors of...
New GABA(B) receptor PAMs revealed in Addex Pharma patents
BioWorld Science
Addex Pharma SA has disclosed new GABA(B) receptor positive allosteric modulators (PAMs) potentially useful for the treatment of chronic cough, urinary...
Meta-analysis: Anti-amyloid Alzheimer’s drugs not ‘clinically meaningful’
BioWorld
The ongoing controversy over the effectiveness of anti-amyloid drugs is about to get more heated, after a review of clinical trials showed statistically...
Novel caspase-2 inhibitor shows in vivo neuroprotective effects
BioWorld Science
Caspase-2-mediated cleavage of tau at Asp314 generates a neurotoxic fragment, Δtau314, that drives early synaptic dysfunction in Alzheimer’s disease (AD) and...